- Home
- EHTH vs TVRD Comparison
EHTH vs TVRD Comparison
Compare EHTH & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- TVRD
- Stock Information
- Founded
- EHTH 1997
- TVRD 2017
- Country
- EHTH United States
- TVRD United States
- Employees
- EHTH N/A
- TVRD N/A
- Industry
- EHTH Specialty Insurers
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- TVRD Health Care
- Exchange
- EHTH Nasdaq
- TVRD Nasdaq
- Market Cap
- EHTH 176.1M
- TVRD 166.5M
- IPO Year
- EHTH 2006
- TVRD N/A
- Fundamental
- Price
- EHTH $5.12
- TVRD $25.61
- Analyst Decision
- EHTH Buy
- TVRD Strong Buy
- Analyst Count
- EHTH 4
- TVRD 1
- Target Price
- EHTH $6.75
- TVRD $39.00
- AVG Volume (30 Days)
- EHTH 364.9K
- TVRD 39.1K
- Earning Date
- EHTH 05-07-2025
- TVRD 05-21-2025
- Dividend Yield
- EHTH N/A
- TVRD N/A
- EPS Growth
- EHTH N/A
- TVRD N/A
- EPS
- EHTH N/A
- TVRD N/A
- Revenue
- EHTH $552,565,000.00
- TVRD N/A
- Revenue This Year
- EHTH $1.38
- TVRD N/A
- Revenue Next Year
- EHTH $8.81
- TVRD N/A
- P/E Ratio
- EHTH N/A
- TVRD N/A
- Revenue Growth
- EHTH 17.04
- TVRD N/A
- 52 Week Low
- EHTH $3.58
- TVRD $8.14
- 52 Week High
- EHTH $11.36
- TVRD $31.32
- Technical
- Relative Strength Index (RSI)
- EHTH 39.41
- TVRD N/A
- Support Level
- EHTH $4.36
- TVRD N/A
- Resistance Level
- EHTH $7.09
- TVRD N/A
- Average True Range (ATR)
- EHTH 0.58
- TVRD 0.00
- MACD
- EHTH 0.01
- TVRD 0.00
- Stochastic Oscillator
- EHTH 27.84
- TVRD 0.00
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.